Outcomes of liver transplant recipients with pretransplant malignancies: Insights from a single institution’s experience. Biomarker testing and targeted therapy use among patients with non-small cell ...

BOSTON — Key DNA and chromosomal and immune cell changes in early-stage lung adenocarcinoma show significant associations with outcomes, representing potentially important early predictors to guide ...

Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...

Researchers built a new atlas of lung cells, uncovering new cellular pathways and precursors in the development of lung adenocarcinoma, the most common type of lung cancer. These findings open the ...

Researchers at The University of Texas MD Anderson Cancer Center built a new atlas of lung cells, uncovering new cellular pathways and precursors in the development of lung adenocarcinoma, the most ...

Tissue inadequacy and operational challenges may limit lung cancer comprehensive biomarker testing. Here, we describe the initial implementation of a tailored tissue molecular journey at Oncoclínicas ...

Lung cancer is classified into two major categories: non-small cell lung cancer (NSCLC), which accounts for 85% of lung cancer cases, and small-cell lung cancer (SCLC), which accounts for the ...

A new AI tool reads lung cancer biopsy slides in under an hour, accurately predicting mutations and saving patients delays, costs and tissue loss, marking a turning point in precision cancer care.

Clinicians using one vendor's algorithm found lung squamous cell carcinoma misdiagnoses, influencing treatment decisions and ...